- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
NovaBiotics wins Life Science Investment of the Year Award
5 February 2016 • Author: Victoria White
Anti-infectives biotechnology company NovaBiotics was awarded the Life Science Investment of the Year Award at the Scottish Enterprise Life Sciences Annual Awards.
The Life Science Investment of the Year Award is presented in recognition of the significance of an investment to a company and its impact on the business and the life science industry in.
NovaBiotics won the award for successfully securing £5 million of equity investment from Woodford Investment Management (WIM) in 2015. The £5 million of capital provided by WIM has been key in NovaBiotics’ continued success and growth in facilitating advancement of its lead R&D programmes; in particular, Lynovex, NovaBiotics’ late-stage clinical candidate cystic fibrosis therapy (in tablet and inhaled form) and Novamycin, a novel antifungal peptide therapy candidate for life threatening fungal infections.
Dr Deborah O’Neil, NovaBiotics Chief Executive Officer said on winning the award: “I’m delighted that NovaBiotics have won this award and with the recognition it signifies – for the whole team – of bringing on board such an important investor. Our deal with WIM was a major milestone for the business and demonstrates recognition of NovaBiotics’ commercial and technical achievements to date and our potential to deliver as a business in the future.”
The awards ceremony on February 4th was held at the Museum of Scotland, hosted as part of Scottish Enterprise’s annual Life Science Dinner, celebrating the success and achievements of Scotland’s internationally renowned life sciences sector in areas including business leadership, investment, innovation, community engagement and collaboration. Scottish Enterprise identifies and exploits opportunities for Scotland’s economic growth by supporting Scottish companies to compete, helping to build globally competitive sectors, attracting new investment and creating a world-class business environment.
Julia Brown, director of life sciences and chemicals at Scottish Enterprise said: “The awards recognise the leading organisations and people in the Scottish life science sector.”
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Butterworth Laboratories Ltd CAPSUGEL NV Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) Eurofins BioPharma Product Testing EUROGENTEC F.P.S. Food and Pharma Systems Srl GE Analytical Instruments IDBS JEOL Europe Kaiser Optical Systems Inc. L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Lonza MA Business Metrohm Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Ocean Optics Panasonic Biomedical Sales Europe B.V. Peak Scientific ReAgent Russell Finex Limited Sentronic GmbH Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Viavi Solutions, Inc Watson-Marlow Fluid Technology Group Wickham Laboratories Limited WITec GmbH Xylem Analytics YMC Europe GmbH Yusen Logistics